Antonio González-Martín
- Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
2023/10/23 by Funda Meric-Bernstam, Funda Meric‐Bernstam, Vicky Makker +22 · 3 citations
Medicine · #Advanced Breast Cancer Therapies #Cancer Treatment and Pharmacology #HER2/EGFR in Cancer Research